Enovix Q2FY26 Results: Revenue up 21% to $9 million
- Revenue rose 21% YoY to $9 million, marking fifth straight quarter of growth
- Cash position stands at $552.1 million, providing ample liquidity for R&D
- Smart eyewear shipments set to increase nine-fold to 19,000 units in Q3
- Defense drone pipeline expanded 45% to $183 million with $100m in drone deals
- Gross margin declined YoY due to product mix shifts in South Korea operations

*this image is generated using AI for illustrative purposes only.
Enovix Corporation (NASDAQ: ENVX) reported second-quarter FY26 revenue of $9 million, a 21% increase year over year. The battery technology firm ended the quarter with $552.1 million in cash, supporting its expansion across smartphones, smart eyewear, and defense markets.
The results marked the fifth consecutive quarter of year-over-year revenue growth. Management highlighted progress in qualifying silicon anode cells for smartphones and ramping production for smart eyewear customers.
Financial Performance
Enovix delivered positive gross profit for the seventh consecutive quarter on both GAAP and non-GAAP bases. The financial highlights include:
| Metric | Q2FY26 | Q2FY25 | Change |
|---|---|---|---|
| Revenue | $9 million | $7.4 million* | +21% YoY |
| Non-GAAP Gross Profit | $1.8 million | - | 19.9% margin |
| Non-GAAP Operating Loss | $28.8 million | - | Better than guidance |
| Free Cash Flow Outflow | $31.4 million | $33.8 million | Improved YoY |
*Derived from stated 21% growth.
Non-GAAP operating expenses rose to $30.6 million from $28.8 million a year ago, reflecting continued investment in smartphone qualification and manufacturing readiness. Adjusted EBITDA improved to negative $18.9 million from negative $20.1 million in the prior year period.
What the Numbers Show
While revenue grew 21%, the non-GAAP gross margin contracted to 19.9% from the prior year period. Management attributed this decline primarily to product mix shifts within the South Korea operations rather than execution issues. This divergence suggests that current volume growth is driven by lower-margin SKUs or early-stage commercial ramps that have not yet achieved scale efficiencies.
Operational Milestones
Smartphone Qualification
The lead customer confirmed Enovix cells passed more than 1,000 cycles in the 0.2 C discharge test. A final accelerated cycle life test is underway, with completion expected by the end of 2026. Sample deliveries to a second smartphone OEM are planned for the fourth quarter.
Smart Eyewear Ramp
Enovix shipped approximately 2,100 batteries to a Tier 1 customer in Q2, recording its first product revenue in this segment. The company has orders for roughly 19,000 packs for the third quarter, representing a nine-fold increase from Q2 volumes.
Defense and Drones
The pipeline for products manufactured in South Korea grew 45% to $183 million, up from $130 million at the end of Q1. Drone opportunities alone now exceed $100 million. More than $40 million of this pipeline is in active testing or design-in stages.
Outlook and Guidance
For the third quarter, Enovix expects revenue between $9 million and $10 million, representing 13% to 25% year-over-year growth. The guidance assumes continued defense shipments and increased smart eyewear deliveries.
Management projects a non-GAAP operating loss between $29 million and $32 million. Capital expenditures are expected to range from $8 million to $12 million, primarily funding Fab 2 upgrades and South Korea capacity expansion targeted for mid-2027.
How might the completion of the smartphone qualification process by late 2026 impact Enovix's revenue trajectory and gross margins in FY27?
What are the potential risks associated with the nine-fold volume increase in smart eyewear shipments for Q3, particularly regarding supply chain stability and quality control?
Given the contraction in non-GAAP gross margin to 19.9%, what specific operational efficiencies or product mix shifts are required to restore profitability as production scales?

































